Crystalloid Fluids

Verify with FDA CVM →

60 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
60
Total Reports
21
Deaths Reported
3500.0%
Death Rate

Active Ingredients

Crystalloid Fluids

Administration Routes

UnknownIntravenousSubcutaneous

Species Affected

Dog 32
Cat 27
Cattle 1

Most Affected Breeds

Domestic Shorthair 15
Retriever - Labrador 4
Retriever - Golden 4
Domestic Longhair 3
Domestic Mediumhair 3
Beagle 2
Dog (unknown) 2
Spaniel - Springer English 2
Persian 2
Doberman Pinscher 2

Most Reported Reactions

Vomiting 14
Other abnormal test result NOS 12
Weight loss 12
Not eating 11
Dehydration 9
Death by euthanasia 9
Behavioural disorder NOS 9
Hyperglycaemia 9
Death 9
Lethargy (see also Central nervous system depression in Neurological) 9
Anorexia 8
Abnormal ultrasound finding 7

Outcome Breakdown

Outcome Unknown
15 (24.6%)
Ongoing
14 (23.0%)
Died
12 (19.7%)
Recovered/Normal
11 (18.0%)
Euthanized
9 (14.8%)

Data Summary

Metric Value
Total adverse event reports 60
Reports involving death 21
Case-fatality rate (reported events) 3500.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Crystalloid Fluids Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 60 adverse event reports referencing Crystalloid Fluids, including 21 reports in which the animal died — a 3500.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Crystalloid Fluids. Reported administration routes include Unknown, Intravenous, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Crystalloid Fluids reports are Dog (32 reports), Cat (27 reports), Cattle (1 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (15), Retriever - Labrador (4), Retriever - Golden (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Crystalloid Fluids are Vomiting (14), Other abnormal test result NOS (12), Weight loss (12), Not eating (11). Of the 61 reports with a coded outcome, Outcome Unknown is the leading category at 24.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Crystalloid Fluids.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial